ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Streptococcal Mannose Phosphotransferase System Component IID Is a Novel RANK-Binding Osteoclastogenic Factor.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Streptococci, Gram-positive opportunistic pathogens, can cause inflammatory bone diseases, yet their virulence factors remain unclear. We investigated streptococcal components contributing to bone pathology. Unlike Staphylococcus aureus, streptococci and lipoprotein-deficient strains induced comparable bone destruction and osteoclastogenesis in mice via a TLR2-independent pathway. A comparative Q Exactive Plus mass spectrometric analysis of streptococcal and staphylococcal membrane proteins led us to identify mannose phosphotransferase system component IID (Man-PTSIID) as a novel osteoclastogenic factor. Recombinant Man-PTSIID and synthetic peptides containing conserved amino acid sequences of Man-PTSIIDs found in various streptococci bound to the receptor activator of nuclear factor-κB (RANK), as demonstrated by an SPR analysis. Structural modeling and molecular docking analysis, together with full-length Man-PTSIID binding assays, demonstrated an interaction between Man-PTSIID and RANK. Streptococcal Man - PTSIID promotes terminal osteoclast maturation and multinucleation following RANKL priming via the RANK signaling pathway, rather than mimicking native RANKL or functioning as an independent RANK agonist. Consistently, the osteoclastogenic effects induced by streptococci were not observed in Man-PTSIID-deficient mutant strains. Collectively, these findings suggest that Man-PTSIID is a novel, differentiation stage-dependent osteoclastogenic factor contributing to terminal osteoclast differentiation and plays a critical role in bone pathology during streptococcal infections.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.